Sonnet BioTherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SONN and buy or sell other stocks, ETFs, and their options commission-free!About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.
CEOPankaj Mohan
CEOPankaj Mohan
Employees12
Employees12
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2011
Founded2011
Employees12
Employees12
SONN Key Statistics
Market cap6.56M
Market cap6.56M
Price-Earnings ratio-1.88
Price-Earnings ratio-1.88
Dividend yield—
Dividend yield—
Average volume104.32K
Average volume104.32K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.97
52 Week high$2.97
52 Week low$0.6239
52 Week low$0.6239
Stock Snapshot
Sonnet BioTherapeutics(SONN) stock is priced at $1.26, giving the company a market capitalization of 6.56M. It carries a P/E multiple of -1.88.
During the trading day, Sonnet BioTherapeutics(SONN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Sonnet BioTherapeutics(SONN) stock has reached 0, versus its average volume of 104.32K.
Over the past 52 weeks, Sonnet BioTherapeutics(SONN) stock has traded between a high of $2.97 and a low of $0.62.
Over the past 52 weeks, Sonnet BioTherapeutics(SONN) stock has traded between a high of $2.97 and a low of $0.62.
People also own
Based on the portfolios of people who own SONN. This list is generated using Robinhood data, and it’s not a recommendation.